Showing posts with label biosafety. Show all posts
Showing posts with label biosafety. Show all posts

Thursday, 31 July 2025

A Guide to Selecting the Right Biological Safety Cabinet (BSCs) for Laboratory Use | Chapter 7 | Microbiology and Biotechnology Research: An Overview Vol. 4q

 

This article provides a structured approach to Biological Safety Cabinets (BSCs) selection by evaluating cabinet classes, types, airflow patterns, containment capabilities, and application-specific requirements. BSCs provide a controlled environment to protect personnel and the laboratory setting from exposure to pathogens, ensuring a safe working space. By aligning cabinet choice with biosafety level, work type, and regulatory standards, laboratories can minimise contamination risks and optimise safety outcomes. There are several types of BSCs, each differentiated by the level of biocontainment they provide to meet the requirements of specific biosafety levels. This article further explores various classes of biological safety cabinets, which are already well-known, their unique features, and their applications in different laboratory settings. Furthermore, the paper underscores the need for informed equipment selection to ensure laboratory safety and compliance with institutional and international biosafety guidelines.

 

Author(s) Details

Eva Troja
Profarma Company, Albania.

 

Please see the book here:- https://doi.org/10.9734/bpi/mbrao/v4/5787

Tuesday, 4 March 2025

Laminar Flow and Biosafety: Essentials for Cleanrooms | Book Publisher International

Cleanrooms play a critical role across various industries, including pharmaceuticals, healthcare, and biotechnology, by providing controlled environments that minimize contamination risks during the manufacturing and research processes. Central to maintaining these sterile conditions is the concept of laminar flow, which is characterized by the unidirectional movement of air that helps reduce the presence of airborne particles. Laminar flow systems are designed to control air movement effectively, ensuring that particulate matter does not compromise sensitive operations.

In the context of cleanroom environments, biosafety measures are essential to safeguard both personnel and products from contamination. These measures encompass various biosafety levels (BSL-1 to BSL-4), which define the containment and safety protocols necessary for handling biological materials. The integration of laminar flow technology with biosafety protocols enhances contamination control, ensuring compliance with regulatory requirements.

Key equipment such as HEPA filters and specialized airflow systems play a vital role in maintaining the integrity of cleanrooms. HEPA filters are crucial for trapping particles and pathogens, while precise airflow control minimizes turbulence and recirculation, further mitigating contamination risks. Biosafety cabinets, which combine these elements, offer a secure environment for working with hazardous materials, reinforcing the importance of both laminar flow and biosafety in the creation of safe and effective cleanroom environments. Through the synergistic use of these technologies, cleanrooms achieve high standards of cleanliness and safety, essential for their critical functions in various scientific and industrial applications.

 

Author (s) Details

Er. Kartik Chauhan
School of Applied Sciences and Technology - GTU, Ahmedabad, Gujarat, India.

 

Dr. Dolatsinh Zala
School of Applied Sciences and Technology - GTU, Ahmedabad, Gujarat, India.

 

Please see the book here:- https://doi.org/10.9734/bpi/mono/978-93-48859-52-5

Friday, 3 March 2023

Biosafety Practices in Mycobacteriology Laboratory | Chapter 1 | Research Advances in Microbiology and Biotechnology Vol. 3

 Mycobacterium infection, the causative agent of infection (TB), is classified as a risk group 3 power, which calls for a Biosafety Level 3 lab (BSL-3) for culture, drug susceptibility experiment, and other lab examinations. Access to a safety laboratory endure be restricted to staff appendages and accredited callers. M. tuberculosis can cause laboratory-seized infections. To guarantee adequate infection control, it is important that a comprehensive and strict biosafety tactics is developed and trailed. Such a policy includes patterned rules and regulations for containment, individual protective supplies (PPE), standard operating procedures (SOP) for different workshop tasks, and a transparent structure for managing safe occupied conditions in diagnostic TB workshops. It is well documented that M. tuberculosis can cause lab-acquired contaminations, and the risk of TB among healthcare workers is usually higher than in the general public. M. tuberculosis even looks in the top-ten list of hazardous agents for lab staff. However, the beginning of the TB infection can only be traced to a distinguishing laboratory accident in a youth of cases. The most important route for lab-acquired infections is aerosols. Thus, contamination control efforts need to focus on restricting the generation of aerosols all along laboratory work, for example, through dependable centrifugation and pipetting. For effective infection control, it is critical that a comprehensive and scrupulous biosafety policy is developed, recognized, and followed by the lab staff. The procedure should include patterned rules and regulations for limit; personal protective supplies (PPE); practical training; standard operating processes (SOPs) for all the different workshop tasks, and transparent and clearly defined levels of maturity for establishing and maintaining secure working environments in the diagnostic TB laboratory.

Author(s) Details:

P. Suganthi,
Department of Medical Microbiology, Institute of Basic Medical Sciences, University of Madras, Tharamani Campus, Chennai, Tamil Nadu, India.

B. Usharani,
Department of Biomedical Genetics, Institute of Basic Medical Sciences, University of Madras, Tharamani Campus, Chennai, Tamil Nadu, India.

R. Venkateswari,
Department of Medical Biochemistry, Institute of Basic Medical Sciences, University of Madras, Tharamani Campus, Chennai, Tamil Nadu, India.

M. Muthuraj,
State TB Training and Demonstration Centre, Intermediate Reference Laboratory, Government Hospital for Chest Diseases, Puducherry, India.

Please see the link here: https://stm.bookpi.org/RAMB-V3/article/view/9759

Tuesday, 12 January 2021

Bioethics and the Development of Biotechnology in Developing Economies: A Case of Nigeria Agricultural Research System (NARS) | Chapter 8 | Cutting-edge Research in Agricultural Sciences Vol. 5

The growth of biotechnologies has been monitored by ethical concerns, particularly as they affect human health and the environment. Such scandals have had a significant influence on the advancement of policies and laws impacting their growth and deployment. Agricultural biotechnology has been at the core of heated national debates, especially in its advanced forms, concerned with manipulating genes. The paper explored the potential of agricultural biotechnology with regard to conjectural threats that could be related to technology. In less developed and food insecure countries such as Nigeria, it attempted to expose the delicate balance between meeting pressing food needs and the potential risks in the use of biotechnology products. Furthermore, the study highlighted the role of ethics in the creation of national biosafety systems and laws. Although the most sealable choice for developing agricultural research systems is considered to be a precautionary posture, ethical concerns must be properly addressed from the outset in order to avoid the experience of developed countries where the production of such agricultural biotechnologies is stiffly resistant.

Author (s) Details

Dr. Thomas Adisa
Federal College of Animal Health and Production Technology, National Veterinary Research Institute, P.M.B.01, Vom, Plateau State, Nigeria.

View Book :-
https://bp.bookpi.org/index.php/bpi/catalog/book/362